[1] Blossom SJ, Gilbert KM. Epigenetic underpinnings of developmental immunotoxicity and autoimmune disease[J]. Curr Opin Toxicol, 2018,10:23-30.
[2] Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases[J]. J Autoimmun, 2009,33(3-4):197-207.
[3] Christen U. Editorial: pathogen infection and autoimmunity[J]. Int Rev Immunol, 2014,33(4):261-265.
[4] Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, healthdisparities and socioeconomic impact[J]. Nat RRev Rheumatol, 2016,12(10) :605-620.
[5] Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review[J]. Semin Arthritis Rheum, 2006,36(3):182-188.
[6] Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression[J]. Nat Genet, 2010,42:295-302.
[7] Simmonds MJ, Heward JM, Howson JM, et al. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves’ disease[J]. Genes Immun, 2004,5:267-273.
[8] Ha H, Han D, Choi Y. TRAF-mediated TNFRfamily signaling[M].Curr Protoc Immunol, 2009,Chapter 11:Unit11.9D.
[9] Magitta NF, Bøe Wolff AS, Johansson S, et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison’s disease and type 1 diabetes[J]. Genes Immun, 2009,10:120-124.
[10] Keogh B, Parker AE. Toll-like receptors as targets for immune disorders[J]. Trends Pharmacol Sci, 2011,32:435-442.
[11] Geddes K, Rubino SJ, Magalhaes JG, et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens[J]. Nat Med, 2011,17:837-844.
[12] Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1[J]. Clinical and experimental immunology, 2012,167:391-404.
[13] Smith S, Fernando T, Wu PW, et al. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE[J]. J Autoimmun, 2017,79:105-111.
[14] Feng S, Jacobsen SE, Reik W. Epigenetic reprogramming in plant and animal development[J]. Science, 2010,330(6004): 622-627.
[15] Rodriguez RM, Suarez-Alvarez B, Mosen-Ansorena D, et al. Regulation of the transcriptional program by DNA methylation during human alphabeta T-cell development[J]. Nucleic Acids Res, 2015,43(2):760-774.
[16] Hashimoto S, Ogoshi K, Sasaki A, et al. Coordinated changes in DNA methylation in antigen-specific memory CD4 T cells[J]. J Immunol, 2013,190(8):4076-4091
[17] Komori HK, Hart T, LaMere SA, et al. Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation[J]. J Immunol, 2015,194(4):1565-1579.
[18] Meyer B, Chavez RA, Munro JE, et al. DNA methylation at IL32 in juvenile idiopathic arthritis[J].Sci Rep, 2015,5:11063.
[19] Hirahara K, Nakayama T. CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm[J]. Int Immunol, 2016,28(4):163-171.
[20] Ivanova EA, Orekhov AN. T helper lymphocyte subsets and plasticity in autoimmunity and cancer: an overview[J]. Biomed Res Int, 2015,2015:327470.
[21] Cardenas A, Koestler DC, Houseman EA, et al. Differential DNA methylation in umbilical cord blood of infants exposed to mercury and arsenic in utero[J]. Epigenetics, 2015,10(6):508-515
[22] Songini M, Mannu C, Targhetta C, et al. Type 1 diabetes in Sardinia: facts and hypotheses in the context of worldwide epidemiological data[J]. Acta Diabetol, 2017,54(1):9-17.
[23] Vaidya SV, Kulkarni H. Association of urinary bisphenol A concentration with allergic asthma: results from the national health and nutrition examination survey 2005–2006[J]. J Asthma, 2012,49(8):800-806.
[24] Anderson OS, Kim JH, Peterson KE, et al. Novel epigenetic bio-markers mediating bisphenol a exposure and metabolic phenotypes in female mice[J]. Endocrinology, 2017,158(1): 31-40.
[25] Cai P, Konig R, Boor PJ, et al. Chronic exposure to trichloroethene causes early onset of SLE-like disease in female MRL +/+ mice[J]. Toxicol Appl Pharmacol, 2008,228(1):68-75.
[26] Cooper GS, Makris SL, Nietert PJ, et al. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans[J]. Environ Health Perspect, 2009,117(5):696-702.
[28] Chan FK, Luz NF, Moriwaki K. Programmed necrosis in the cross talk of celldeath and inflammation[J]. Annu Rev Immunol, 2015,33:79-106.
[29] Ehl S, Hombach J, Aichele P, et al. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo signifcance in a transgenic mouse model[J]. J Exp Med,1997,185:1241-1251.
[30] Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity[J]. Lancet Infect Dis, 2002,2:156-162.
[31] Fujinami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev, 2006,19:80-94.
[32] Walker JA, McKenzie ANJ. TH2 cell development and function[J]. Nat Rev Immunol, 2018,18:121-133.
[33] Sinha S, Subramanian S, Miller L, et al. Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand[J]. J Neurosci, 2009,29:3816-3823.
[34] Filippi CM, Estes EA, Oldham JE, et al. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice[J]. J Clin Invest, 2009,119:1515-1523.
[35] Christen U, Benke D, Wolfe T,et al.Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient[J]. J Clin Invest, 2004,113:74-84.
[36] Vessey MP, Villard-Mackintosh L, Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis[J]. Contraception, 1987,35(5):457-464.
[37] Heliovaara M, Aho K, Aromaa A, et al. Smoking and risk of rheumatoid arthritis[J]. J Rheumatol,1993,11:1830-1835.
[38] Karlson EW, Lee IM, Cook NR, et al. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals[J]. Arthritis Rheum,1999,42:910-917.
[39] Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles[J]. Ann Rheum Dis, 2006,65(3):366-371.
[40] Holm IA, Manson JE, Michels KB, et al. Smoking and other lifestyle factors and the risk of Graves’ hyperthyroidism[J]. Arch Intern Med, 2005, 165:1606-1611.
[41] Kiyohara C, Washio M, Horiuchi T, et al. Cigarette smoking, alcohol consumption, and risk of systemic lupus erythematosus: a case-control study in a Japanese population[J]. J Rheumatol, 2012,39(7):1363-1370.
[42] Ghadirian P, Dadgostar B, Azani R, et al. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis[J]. Can J Public Health,2001,92:281-85.
[43] Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients[J]. Hepatology,2005, 42:1194-1202.
[44] Larsson I, Andersson MLE, BARFOT study group. Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study[J]. BMJ Open, 2018, 8(12):e024367.
[45] Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders[J].Cancer Treat Rev, 2004,30(4):369-384.
[46] Cooper GS,Wither J,Bernatsky S,et al.Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents[J].Rheumatology (Oxford),2010,49(11): 2172-2180.
[47] Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment[J]. Autoimmun Rev,2010,9(5):A387-394.
[48] Kreutz M, Andreesen R, Krause SW,et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages[J]. Blood,1993,15;82(4):1300-1307.
[49] Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis[J]. Neurology,2004,13; 62(1):60-65.
[50] Di Giuseppe D, Wallin A, Bottai M, et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women[J]. Ann Rheum Dis, 2014,73(11):1949-1953.
[51] Jelinek GA, Hadgkiss EJ, Weiland TJ, et al. Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis[J]. Int J Neurosci, 2013,123(11):792-800.
[52] Riccio P, Rossano R. Nutrition facts in multiple sclerosis[J]. ASN Neuro, 2015,18;7(1).
[53] Chen GQ, Chen YY, Wang XS, et al. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats[J]. Brain Res,2010,14;1309:116-125.
[54] Hedström AK, Mowry EM, Gianfrancesco MA, et al. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies[J]. J Neurol Neurosurg Psychiatry,2016,87(5):454-460.
[55] Pitocco D, Zaccardi F, Di Stasio E,et al. Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus[J]. Diabetes Res Clin Pract,2009 ,86(3):173-176.
[56] Uzawa A, Mori M, Taniguchi J, et al. Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis[J]. Clin Exp Immunol,2014,178(2):245-252.
[57] Neuhaus O, Hartung HP. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis[J]. Expert Rev Neurother,2007,7(5):547-556.